Medtech 100 - EU Outlook 2023: Will The Road Ahead Be Any Smoother For The EU’s Medtech Regulations?
Originally intended to increase medical device safety, the implementation of the EU’s medtech regulation was so hampered in 2022 that it had started to look as if the new regulations were a bigger potential threat to patients than any of the scandals leading to its more stringent requirements. With the European Commission’s latest plans to ease challenges around implementation, will 2023 be a more positive year for the EU medtech sector?
You may also be interested in...
Podcast: Medtech 100 And 2023 Outlook Published
Medtech Insight’s annual listing of the leading medtech companies by revenues is now available on the Medtech Insight website.
BSI Notified Body Highlights Crucial Elements Related To EU’s MDR Amending Regulation
BSI Group has issued a useful Q&A document on how it sees the new EU MDR amending Regulation, which extends the transition deadlines for legacy medical devices, impacting manufacturers and their relationship with notified bodies.
European Commission Proposes First “Master UDI-DI” - For Contact Lenses
Medtech stakeholders are being invited to comment on a proposed delegated regulation, the type of which could eventually be relevant for more than just contact lenses.